ROSE DIAGNOSTICS INC.

CARLSBAD, CA · Founded 2023 · Medtech · Private

Lung cancer biopsy guidance technology to improve diagnostic accuracy and reduce procedure time

Claim this profile

Follows are private to you and power your alerts

Updated · rose-dx.com

Sector
Medtech
Headquarters
CARLSBAD, CA
Founded
2023
Latest Form D
$2.2M, Sep 2026
Total capital
$5.6M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$5.6M
3 Form D · last Sep 2026
1 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
0
2 pending

Capital timeline

202420252026FEDERAL ↑EQUITY ↓Cumulative $5.6M1st Form D$1M2nd Form D$2.3M3rd Form D$2.2M
202420252026FEDERAL ↑EQUITY ↓Cumulative $5.6M1st Form D$1M2nd Form D$2.3M

Latest events

  • Private capital raisedForm D · SEC · 3rd filing$2.2M
  • Private capital raisedForm D · SEC · 2nd filing$2.3M
  • Private capital raisedForm D · SEC · 1st filing$1M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Founders and team

From SEC Form D filings
  • Adolfo VelazquezExecutive Officer, DirectorNamed in SEC Form D filings
  • Andrew MorrisExecutive Officer, DirectorNamed in SEC Form D filings
  • Donna PadavanExecutive Officer, DirectorNamed in SEC Form D filings
  • Eric BrouwerExecutive Officer, DirectorNamed in SEC Form D filings
  • Paul GoldDirectorNamed in SEC Form D filings

What it has protected

USPTO · 0 granted of 2
  • PendingMethods To Stabilize Chemokine Proteins In Solution And For Point Of Care Detection Of Stabilized Chemokine ProteinsUSPTOApplication PCTUS2025015284
  • PendingMethods To Stabilize Lymphoid Proteins In SolutionUSPTOApplication 63551187

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .